MYCi361
MYCi361 is an inhibitor of MYC (binding to MYC with Kd of 3.2 μM) . MYCi361 is a small-molecule MYC inhibitors that inhibits the viability of MYC-dependent cancer cells including prostate cancer (MycCaP, LNCaP, and PC3), leukemia (MV4-11), lymphoma (HL-60 and P493-6), and neuroblastoma (SK-N-B2) with low-micromolar IC50 values.
Product Specifications
CAS Number
2289690-31-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
594.86
Molecular Formula
C26H16ClF9N2O2
Notes
Research use only, not for human use.
Receptor
MYC
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal Dityrosine Antibody (10A6) [FITC]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
MBS6500771-01 0.1 mL
ST2, NT (Suppressor of Tumorigenicity 2, ST2L, ST2V, DER4, Homolog of Mouse Growth Stimulation-expressed, Interleukin 1 Receptor-like 1, IL1RL1, Interleukin 1 Receptor-related Protein, Lymphocyte Antigen 84, Ly84, T1 Protein) (FITC)
Ask
View Details 
MBS6500771-02 5x 0.1 mL
ST2, NT (Suppressor of Tumorigenicity 2, ST2L, ST2V, DER4, Homolog of Mouse Growth Stimulation-expressed, Interleukin 1 Receptor-like 1, IL1RL1, Interleukin 1 Receptor-related Protein, Lymphocyte Antigen 84, Ly84, T1 Protein) (FITC)
Ask
View Details